2025 Publications
2025 Publications
O'Mahony, A.G., Mazzocchi, M., Morris, A., Morales-Prieto, N., Guinane, C., Wyatt, S.L., Collins, L.M., Sullivan, A.M., * O'Keeffe, G.W.* (2025) The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson's disease. Neuropharmacology. 2025 Jan 20:110319
2. Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones
Kruschel, R. D., Malone, K., Walsh, A. N., Waeber, C., & McCarthy, F. O. (2025). Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones. Pharmaceuticals, 18(2), 268.
Valderrama B, Daly I, Gunnigle E, O'Riordan KJ, Chichlowski M, Banerjee S, Skowronski AA, Pandey N, Cryan JF, Clarke G, Nagpal J. From in silico screening to in vivo validation in zebrafish - a framework for reeling in the right psychobiotics. Food Funct. 2025 Feb 18.
4. Evaluating student understanding of core pharmacokinetic concepts
Babey AM, Koenig J, Cunningham M, Shield A, Restini C, Djouma E, Mraiche F, Mifsud J, Kelly JP, Nicolazzo J, Karpa KJ, Volbrecht K, Santiago MJ, Hawes M, Aljofan M, Kelly-Laubscher R, Karunaratne N, Tucker SJ, Hinton T, Liang W, Guilding C, White PJ. Evaluating student understanding of core pharmacokinetic concepts. Eur J Pharmacol. 2025 Mar 5;990:177256.
5. Evaluating student understanding of pharmacodynamics core concepts
Kelly-Laubscher R, Koenig J, Cunningham M, Aljofan M, Babey AM, Hawes M, Hinton T, Karpa K, Karunaratne N, Nicolazzo J, Liang W, Mraiche F, Restini C, Santiago M, Volbrecht K, Guilding C, White PJ. Evaluating student understanding of pharmacodynamics core concepts. Eur J Pharmacol. 2025 Mar 5;990:177257
6. Exploring the knowledge demands of a pharmacology assessment using Legitimation Code Theory
Pignatelli-Espejo A, Kelly-Laubscher R, Barry ÓP. Exploring the knowledge demands of a pharmacology assessment using Legitimation Code Theory. Eur J Pharmacol. 2025 Feb 23;996:177411